Development of a risk score for major bleeding associated with novel oral anticoagulants

• In: Short oral presentations, Part 2b (Practice & Education) on Tuesday, 30 August 2016, 16:10-16:20
• At: Buenos Aires (Argentina) (2016)
• Type: Presentation
• By: HERTIG, John (Purdue University College of Pharmacy, Center for Medication Safety Advancement, Indianapolis, United States)
• Co-author(s): Janelle Lenz:Center for Medication Safety Advancement,Purdue University College of Pharmacy,Indianapolis,United States|John Hertig:|Dan Degnan:Center for Medication Safety Advancement,Purdue University College of Pharmacy,Indianapolis,United States|Heather Jaynes:|James Tisdale:Pharmacy Practice,Purdue University College of Pharmacy,Indianapolis,United States
  
• Abstract:

  Use of novel oral anticoagulants (NOACs) is increasing. While risk scores exist for patients taking warfarin, a risk score for major bleeding associated in patients taking NOACs for a broad range of indications has not been developed. 

  In this retrospective study, Indiana University Health System medical records were used to identify patients that

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login